Publications

PABLO LUIS ORTIZ ROMERO publications

244 results

2026

  1. Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee

    Journal of the European Academy of Dermatology and Venereology, Vol. 40, Núm. 2, pp. 174-184

  2. Comment on ‘Context, not class, may be the key signal in systemic Janus kinase inhibitor exposure in mycosis fungoides/Sézary syndrome’: reply from authors

    British Journal of Dermatology

  3. Cutaneous Toxicities of Anti-GPRC5D Bispecific Antibodies for Multiple Myeloma: Retrospective Study

    Journal of Dermatology

  4. DRESS syndrome triggered by brentuximab vedotin in Sézary syndrome treated with mogamulizumab: a novel association

    JDDG - Journal of the German Society of Dermatology

  5. Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group

    Journal of Allergy and Clinical Immunology, Vol. 157, Núm. 6, pp. 1237-1245

  6. Evaluation of the Risk of Psoriatic Arthritis in Patients With Psoriasis Undergoing Biological Treatment. Global Population Study (TRINETX)

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 1

  7. Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

    Journal of the European Academy of Dermatology and Venereology, Vol. 40, Núm. 1, pp. 99-108

  8. Multicenter Observational Study on Recurrence Patterns and Health Care Resource Utilization in Stage II Cutaneous Melanoma in Spain: Real-world Evidence From the METHEOR Study

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 8

  9. Mycosis fungoides/Sézary syndrome and systemic Janus kinase inhibitors: a real-world retrospective study on behalf of the EORTC CLTG

    British Journal of Dermatology

  10. Oncologic Safety in Solid Organ Transplant Recipients With a Past Medical History of Early-stage Melanoma: A Retrospective Cohort Study

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 8

  11. Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

    The Lancet Haematology, Vol. 13, Núm. 2, pp. e98-e109

  12. Safety of biologic therapy in psoriasis patients with a previous malignancy: Retrospective study using TriNetX

    JDDG - Journal of the German Society of Dermatology

  13. Translation, Cross-cultural Adaptation, Correlation With Other PROMs and Validation of the MF/SS-CTCL-QoL Questionnaire on Quality of Life in Mycosis Fungoides (MF) and Sézary Syndrome (SS)

    Actas Dermo-Sifiliograficas, Vol. 117, Núm. 5

2025

  1. A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

    Blood, Vol. 146, Núm. 14, pp. 1687-1692

  2. Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee

    Bone Marrow Transplantation, Vol. 60, Núm. 12, pp. 1565-1573

  3. Comparative effect of metformin and SGLT2i on vascular risk and mortality in hidradenitis suppurativa

    Journal of the European Academy of Dermatology and Venereology

  4. Early-stage mycosis fungoides: searching for biomarkers associated with advanced-stage progression

    British Journal of Dermatology, Vol. 193, Núm. 5, pp. 1019-1021

  5. European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders

    The British journal of dermatology

  6. Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome

    Journal of the European Academy of Dermatology and Venereology, Vol. 39, Núm. 4, pp. 833-845

  7. ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging

    British Journal of Dermatology, Vol. 193, Núm. 3, pp. 405-414